Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Excitatory Amino Acid Antagonists”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT00108667
What this trial is testing

Talampanel to Treat Parkinson's Disease

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 40
Early research (Phase 1)Study completedNCT02577250
What this trial is testing

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantStress Disorders, Post-Traumatic
Minneapolis Veterans Affairs Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00001930
What this trial is testing

Treatment of Huntington's Chorea With Amantadine

Who this might be right for
ChoreaHuntington's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25
Testing effectiveness (Phase 2)Study completedNCT00001929
What this trial is testing

Treatment of Parkinson's Disease With Eliprodil

Who this might be right for
Movement DisordersParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Testing effectiveness (Phase 2)Study completedNCT00001365
What this trial is testing

Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

Who this might be right for
Neurodegenerative DiseaseParkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 42
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)Study completedNCT03051256
What this trial is testing

Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD

Who this might be right for
Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Relmada Therapeutics, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Testing effectiveness (Phase 2)Study completedNCT00251303
What this trial is testing

Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders

Who this might be right for
Obsessive-Compulsive DisorderAutism Spectrum DisorderAutism+2 more
National Institute of Mental Health (NIMH) 78
Testing effectiveness (Phase 2)WithdrawnNCT05991232
What this trial is testing

Repeated Neurocognitive Measurements in Depressed Patients

Who this might be right for
Depression, Unipolar
Jay Fournier
Early research (Phase 1)Study completedNCT04032301
What this trial is testing

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Who this might be right for
Post-Traumatic Stress DisordersMajor Depressive Disorder
University of Minnesota 67
Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Theresa Jacob, PhD, MPH 15
Post-approval studies (Phase 4)Study completedNCT01018056
What this trial is testing

Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission

Who this might be right for
Tourette Syndrome
Johns Hopkins University 39
Large-scale testing (Phase 3)Study completedNCT02967640
What this trial is testing

Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?

Who this might be right for
Rotator Cuff TendinitisChronic Pain
Helse Møre og Romsdal HF 14